ClinicalTrials.gg
RecruitingNCT07503951Updated Jun 3, 2026

Cognitive Behavior Therapy in Psychiatric Inpatient Care

An interventional study of Cognitive Behavioral Therapy and treatment as usual (TAU) (Control Group) in Depression, Anxiety Disorders and Psychiatric Inpatients, sponsored by Region Stockholm. Recruiting at 1 site in Sweden. Per ClinicalTrials.gov, last updated 2026-06-03.

Sponsored by Region Stockholm · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Apr 2026; still recruiting 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
204
Allocation
Randomized
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 183 studies in Depression with a site in Sweden — 34 open to participants now, 47 under way, 1 of them phase 3. Depression · Sweden.

Planned enrollment
46th of 156
204 · median 113
Started
2026
with 5 others
No phase
124 of 183
24 open now
Primary completion
2027-12
later than 38 of 46 live
Registered
176th of 183
by date
Lead sponsor
8 of 183
Region Stockholm

Among the 183 studies in Depression with a site in Sweden, this one is the 46th largest by planned enrollment of the 156 interventional ones that give a count, is one of 6 that started in 2026, is one of 124 with no phase, reaches primary completion later than 38 of the 46 other live ones, and was the 176th registered.

Depression

8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.

Browse Depression studies →

Open to participants now

34 of the 183 studies in Depression with a site in Sweden are open now. Recruiting first, the newest first:

28 more — sign in →

All 34 open studies →

A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →

Who these studies take

Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 183 studies in Depression with a site in Sweden, or all of them as a file.
02

Study summary

The current project aims to evaluate the extent to which psychological interventions based on Cognitive Behavioral Therapy (CBT), provided within the framework of care, may be helpful for patients in psychiatric inpatient care. The background to the project is the substantial lack of psychological treatment available to patients in psychiatric inpatient care, despite evidence suggesting that active psychological interventions can have a positive effect on psychiatric problems, such as reduced depressive symptoms, decreased anxiety, and reduced rates of readmission to inpatient psychiatric care. Previous research evaluating the effects of CBT in inpatient settings is, however, rare and more knowledge is needed both nationally and internationally. In addition to the potential direct effect of psychological treatment on patients' difficulties, there is also a high demand for such support from patients, for example, as expressed at patient forums conducted by participation coordinators in Region Stockholm, Sweden. In psychiatric outpatient and primary care, there is currently good evidence supporting CBT, and these methods are highly beneficial for both patients and practitioners. Digitalization and blended formats, with therapist-supported internet treatments, can also increase access to interventions. Studies of CBT for, for example, depression, anxiety, and psychosis are well documented and have shown a significant reduction in psychiatric symptoms as well as improved quality of life. But scarcity of studies conducted in inpatient care limits available knowledge on feasibility and effects of CBT interventions to this group of patients. This strongly motivates further systematic evaluation and research on CBT in inpatient psychiatric care, and the aim of the present study is to implement and evaluate CBT in this context. Investigators plan to test this at four to six psychiatric inpatient units and evaluate the impact of the intervention on patients' levels of activity and symptoms of low mood and depression in a randomized controlled trial. In addition, investigators wish to conduct two different interview studies with patients and staff to obtain a detailed description of how they experience the intervention.

Read the detailed description

Access to psychological treatment and Cognitive Behavioral Therapy (CBT) is limited in Swedish psychiatric inpatient care, despite increased support for the usefulness and effects of CBT in outpatient care. Although more research is needed from inpatient contexts, initial studies shows that CBT can provide positive effects beyond medication, including reduced readmission rates and alleviated symptoms. This study aims to investigate whether CBT delivered by mental health professionals is feasible and beneficial for patients in inpatient care.

The project includes three separate studies and the present registration concerns study 1, a randomized controlled study to evaluate the effects of the intervention. Study 2 and 3 are qualitative studies exploring the experiences of the intervention from the perspectives of mental health professionals (study 2) and patients (study 3). The primary research questions in study 1 are:

  1. Do participants who receive brief CBT during their inpatient care report significantly higher activity levels of behavioral activity, as measured by BADS-SF (Behavioral Activation Depression Scale - Short Form), compared to participants who receive treatment as usual?
  2. Do participants who received brief CBT during their inpatient care period report significantly higher levels of perceived health, as measured by CORE-10 (Clinical Outcome in Routine Evaluation - 10), compared to participants who receive treatment as usual?

In total, 204 participants are recruited from four to six psychiatric inpatient units in Stockholm (Sweden) and at each individual unit, participants are randomized to one of two conditions: (1) CBT or (2) Treatment as usual. At the units where the study is conducted, a structured approach to offering conversations called Daily Conversations (DC) are a part of the usual inpatient care. The effects of the intervention/brief CBT are evaluated using psychometrically validated self-report questionnaires, which are collected during routine admission interviews and conducted by nursing staff on each ward. At admission, information about the study is provided and participants' consent is collected. This can also take place at a later time if the staff considers it appropriate. To increase the likelihood of obtaining participants self-reports at discharge and minimize attrition, investigators are also using digitalized questionnaires delivered via smartphone applications or computer. In addition, the patients rate patient satisfaction and experience of the treatment intervention prior to discharge from psychiatric care. Questionnaires have been chosen due to their psychometric properties and are widely used in research on patients with psychiatric problems/symptoms. To avoid burdening participants and staff with excessive administration, investigators have chosen instruments with few questions, and that are already used in inpatient care. In addition to self-report questionnaires, data from medical records of each participant are collected with written consent. This includes information on periods of care in psychiatric inpatient settings during the months prior to and following discharge, coercive measures during the care period, medication, and current diagnoses for each participant. These data are used to describe the sample of enrolled participants, and to facilitated assessment of external validity and generalizability of findings. Follow-up will be conducted at three months following discharge, and at one year following discharge.

Statistical analysis is performed using LMM (Linear Mixed Model) analysis of main effects of each condition, interaction effects of group and time (effect of the intervention). Descriptive analysis of demographic data is performed to characterize the sample.

Reporting of the results follows the recommendations provided by the CONSORT guidelines (Consolidated Standards for Reporting Trials). To meet the requirements for a higher scientific standard and increase transparency and quality, the study is pre-registered on ClinicalTrials.gov. To further facilitate external review, Rob2 (Risk-of-bias 2), Cochrane's tool for assessing risk of bias in randomized trials, is used.

The intervention is called "Brief CBT" and consists of psychological therapy sessions based on elements of Cognitive Behavioural Therapy (CBT), Acceptance and Commitment Therapy (ACT), and Behavioural Activation (BA). The treatment is manualized and focuses on training patients to engage in activities that are meaningful and enhance quality of life in both the short and long term. During the sessions, patients receive support in focusing on and articulating what they perceive as important and meaningful for themselves, and they are helped to manage distressing thoughts and feelings. The manual serves as a support and working material for staff and patients, providing structure for the sessions. It also allows the patient to read and learn more about the content at any time, which increases their participation and involvement in the treatment. The goal is for the intervention to be delivered daily, but if this is not possible, staff are encouraged to offer sessions every other or every third day. This is because the length of inpatient care periods in psychiatric wards is limited. A treatment session can be as short as 15 minutes but also up to an hour. The length is adjusted to how long the patient can actively participate. If the patient is hospitalized for a longer period, the number of sessions can be increased according to their wishes. This is particularly relevant for units with longer care periods, such as psychosis and geriatric psychiatry wards.

Training for staff consists of four half-days covering theory and practical exercises focused on key parts of the manual/intervention. The following areas are addressed:

  • Basic knowledge of cognitive behavioral therapy.
  • Focus on structure, working alliance/relationship, and intervention/change in sessions.
  • Basic interventions regarding goals, values, and focus on meaningful activities.• Basic psychoeducation and interventions focused on behavioral activation and discovering the connection between activity and well-being.
  • Individually tailored interventions for sleep difficulties, managing and regulating emotions, handling voices, problem-solving skills, breathing, and relaxation exercises.
  • Managing termination and planning for maintenance after discharge.

After completion of the initial training, 12 biweekly group supervision are sessions held, given to each ward. This is to provide opportunities for active participation for everyone in the group and to enhance the conditions for learning. The duration for implementing the training and supervision for each unit is approximately six months.

03

Conditions studied

  • Depression, Anxiety Disorders
  • Psychiatric Inpatients

Keywords

  • Cognitive Behavioral Therapy
  • Inpatient Psychiatric Care
  • Mental Health Professionals
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Admitted as patient in Psychiatric Inpatient Care
  • Expected to remain admitted on the ward for at least 3 days
  • Assessed as being capable of giving consent regarding participation.
  • Assessed as able to engage in and complete conversations.
  • Sufficient level of language skills to understand the content of conversations and client material included in the intervention.

Exclusion criteria

Exclusion Criteria:

  • Other ongoing psychotherapeutic contact.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
204 participants (estimated)

Study arms

  • Other
    Treatment as usual (TAU)

    Participants in this arm are provided the treatment usually given during admission at the ward. This includes medication, routine brief conversation offered daily, and other activities at the ward.

    Other: treatment as usual (TAU) (Control Group)

  • Experimental
    Cognitive Behavioral Therapy

    Patients are given therapeutic conversations during admission. The sessions are delivered by mental health professionals at the ward who have received training in the structure of the manual and specific interventions included. The interventions delivered during the therapeutic conversations are based on Cognitive Behavior Therapy (CBT), Acceptance and Commitment Therapy (ACT), and Behavioral Activation(BA).

    Behavioral: Cognitive Behavioral Therapy

Interventions

  • BehavioralCognitive Behavioral Therapy

    Inpatients at the ward receives manual-based CBT during admission. The sessions are delivered by mental health professionals.

  • Othertreatment as usual (TAU) (Control Group)

    Including medical treatment, other activities at the ward, offering of daily conversations (DC)

06

What researchers measure

Primary outcomes

  1. Behavioral Activation Depression Scale - Short Form (BADS-SF)

    Measures self-reported level of behavioral activation. 9 items with a total score of 0-54. Higher scores indicates higher levels of behavioral activation.

    Time frame: Change from baseline (at admission) to discharge, up to four weeks. Follow-up will be collected three months and one year following discharge.

  2. Clinical Outcomes in Routine Evaluation - 10 (CORE-10)

    CORE-10 measures mental health, capturing a broad range of psychological and functional domains. It consists of 10 items (0-4) and scoring results in a total score with higher scores indicating more psychiatric symptoms.

    Time frame: Change from baseline (at admission) to discharge, up to four weeks. Follow-up will be collected three months and one year following discharge.

Secondary outcomes

  1. EQ-5D-5L (EuroQol)

    Measures of self-reported level of health. Scoring results in two separate variables, (1) a self-reported VAS-scale ranging from 0 to 100 where higher scoring indicates higher levels of health, and (2) an index from 0 to 1 where higher index indicate higher levels of health.

    Time frame: Change from baseline (at admission) to discharge, up to four weeks. Follow-up will be collected three months and one year following discharge.

  2. Days in inpatient psychiatric care

    Each participants amount of days admitted in inpatient psychiatric care. Data are retrieved from participants medical records.

    Time frame: (1) three months prior to admission, and (2) three months following discharge. Follow-up will be collected during three months up to one year following discharge.

  3. Clinical Global Impression (CGI)

    CGI is a structured three-item observer-rated tool to capture severity of problems (CGI-S), improvement (CGI-I), and treatment efficacy (CGI-E). For the purpose of this study, the first two items will be used. The rating gives a score ranging from 1 to 7. On CGI-S, lower scores indicate less severity of problems. On CGI-I, lower scores indicate more improvement.

    Time frame: Change from baseline (at admission) to discharge, up to four weeks. Follow-up will be collected three months and one year following discharge.

Other outcomes

  1. Experience of the psychosocial support/conversations in PIC

    A self-report questionnaire with 7 items capturing the patients experiences of the intervention. Items are rated from 1 to 7 with a total score of 7 to 49. Higher ratings indicate higher levels of positive experiences of the support.

    Time frame: Administered to participants up to four weeks from admission/baseline.

  2. Patient satisfaction

    A self-report questionnaire to capture satisfaction of inpatient care. Three items are rated from 0 to 10. Higher ratings indicate higher levels of satisfaction. An open-ended question to capture more elaborate answers is included.

    Time frame: Administered to participants up to four weeks from admission/baseline.

07

Study locations

1 of 1 sites recruiting
  • Centrum för psykiatriforskning, Region Stockholm
    Stockholm, 11354, Sweden
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Individual participant data on all outcome variables will be shared via a repository at Karolinska Institutet, KI Data Repository (https://kib.ki.se/en/publish-analyse/publish-and-share-research-data/ki-data-repository). This includes data on primary as well as secondary outcomes.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Analytic code

Time frame: The IPD and supporting information will be available when the manuscript will be submitted. The planned date for submitting the manuscript for this study is December 2028.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2026 (actual). Primary completion is estimated for Dec 2027, 20 months after the start.

Of 3,486 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 20 months is close to that.

Counting every sponsor, half of 3,584 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 10, 2026
First posted
Mar 31, 2026
StartActual
Apr 1, 2026
Primary completionEst.
Dec 31, 2027
CompletionEst.
Mar 31, 2028
Last update
Jun 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07503951
Lead sponsor
Region Stockholm
Collaborators
Karolinska Institutet, Stockholm University
Responsible party
Sponsor
First posted
Mar 31, 2026
Start date
Apr 1, 2026
Primary completion
Dec 31, 2027 (estimated)
Completion
Mar 31, 2028 (estimated)
Last update
Jun 3, 2026

Study contacts

Johan Holmberg, PhD
Contact
johan.holmberg.1@ki.se
+46708235089
Johan Holmberg, PhD
principal investigator · Centre for Psychiatry Research, Region Stockholm/Karolinska Institutet

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion